Can androgen deprivation therapy be deferred in select group of patients with prostate cancer who are not suitable for curative local treatment?
Main Authors: | A Karthikeyan, Nitin S Kekre |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2006-01-01
|
Series: | Indian Journal of Urology |
Online Access: | http://www.indianjurol.com/article.asp?issn=0970-1591;year=2006;volume=22;issue=4;spage=385;epage=386;aulast=Karthikeyan |
Similar Items
-
Cardiovascular toxicities of androgen deprivation therapy in Asian men with localized prostate cancer after curative radiotherapy: a registry-based observational study
by: Youquan Li, et al.
Published: (2022-03-01) -
Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: Where is the evidence?
by: T J Nirmal, et al.
Published: (2010-01-01) -
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
by: Shtutman Michael, et al.
Published: (2010-04-01) -
Survival following primary androgen deprivation therapy among men with localized prostate cancer
by: Pawan Vasudeva, et al.
Published: (2008-01-01) -
Trends in Androgen Deprivation Use in Men With Intermediate-Risk Prostate Cancer Who Underwent Radiation Therapy
by: Vishesh Agrawal, MD, et al.
Published: (2022-07-01)